Vaccine Information Statement (VIS) -- Hepatitis B Vaccine: What You Need to Know
This two-page Vaccine Information Statement (VIS) educates people about the vaccination for hepatitis B, a serious disease that affects the liver. It provides facts about acute hepatitis B virus infection (a short-term illness), and chronic hepatitis B virus infection (a long-term illness). It describes hepatitis B symptoms, transmission, and effects. The document clarifies that the vaccine is usually given as 3 or 4 shots over 6-months, provides recommended ages for when infants, children, and adolescents should be vaccinated, and identifies those unvaccinated adults who are at risk for hepatitis B virus infection, as well as those who should not get the vaccination. It discusses risks and side effects, and what to look for and what to do in the event of a severe allergic reaction. Contact information for the National Vaccine Injury Compensation Program (VICP) is provided, along with tips for how people can learn more about the hepatitis B vaccine.
The English-language VIS was created by the Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases. The translations are provided by the Immunization Action Coalition (IAC) and its partner organizations. The Indonesian, Japanese, Nepali, and Oromo translations are based on the 07/20/2016 CDC version. All other translations are updated to the October 2018 VIS. The 2018 edition of the Hepatitis B VIS does not differ appreciably from the 2016 edition. The only change in content is one sentence within section 2, from “The vaccine is usually given as 3 or 4 shots over a 6-month period” to "The vaccine is usually given as 2, 3, or 4 shots over 1 to 6 months."
A qualified translation company performed an independent review by a second translator, and a client advocate.